vs

Side-by-side financial comparison of MANNATECH INC (MTEX) and NeuroPace Inc (NPCE). Click either name above to swap in a different company.

MANNATECH INC is the larger business by last-quarter revenue ($29.2M vs $26.6M, roughly 1.1× NeuroPace Inc). MANNATECH INC runs the higher net margin — 6.6% vs -10.3%, a 16.9% gap on every dollar of revenue. On growth, NeuroPace Inc posted the faster year-over-year revenue change (23.9% vs -8.1%). NeuroPace Inc produced more free cash flow last quarter ($409.0K vs $-2.0M). Over the past eight quarters, NeuroPace Inc's revenue compounded faster (21.1% CAGR vs -5.4%).

Mannatech Inc. is a publicly traded, multinational multi-level marketing firm that sells dietary supplements and personal care products. It was founded in November 1993 by Samuel Caster, and is headquartered in Flower Mound, Texas. The company's stock is traded on the NASDAQ exchange under the symbol MTEX. As of 2017, Mannatech employed 252 people and sold its products through some 220,000 independent sales associates.

NeuroPace Inc is a medical technology company focused on developing and commercializing innovative implantable neurostimulation systems to treat neurological disorders, primarily drug-resistant epilepsy. Its core RNS System delivers personalized responsive stimulation to reduce seizure frequency, serving patients across North America and select global markets via partnerships with healthcare providers.

MTEX vs NPCE — Head-to-Head

Bigger by revenue
MTEX
MTEX
1.1× larger
MTEX
$29.2M
$26.6M
NPCE
Growing faster (revenue YoY)
NPCE
NPCE
+31.9% gap
NPCE
23.9%
-8.1%
MTEX
Higher net margin
MTEX
MTEX
16.9% more per $
MTEX
6.6%
-10.3%
NPCE
More free cash flow
NPCE
NPCE
$2.4M more FCF
NPCE
$409.0K
$-2.0M
MTEX
Faster 2-yr revenue CAGR
NPCE
NPCE
Annualised
NPCE
21.1%
-5.4%
MTEX

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
MTEX
MTEX
NPCE
NPCE
Revenue
$29.2M
$26.6M
Net Profit
$1.9M
$-2.7M
Gross Margin
76.4%
77.4%
Operating Margin
6.9%
-6.6%
Net Margin
6.6%
-10.3%
Revenue YoY
-8.1%
23.9%
Net Profit YoY
686.6%
48.0%
EPS (diluted)
$1.01
$-0.08

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
MTEX
MTEX
NPCE
NPCE
Q4 25
$26.6M
Q3 25
$29.2M
$27.4M
Q2 25
$23.5M
Q1 25
$26.6M
$22.5M
Q4 24
$29.0M
$21.5M
Q3 24
$31.7M
$21.1M
Q2 24
$27.7M
$19.3M
Q1 24
$29.4M
$18.1M
Net Profit
MTEX
MTEX
NPCE
NPCE
Q4 25
$-2.7M
Q3 25
$1.9M
$-3.5M
Q2 25
$-8.7M
Q1 25
$-1.5M
$-6.6M
Q4 24
$2.3M
$-5.3M
Q3 24
$-328.0K
$-5.5M
Q2 24
$-624.0K
$-7.5M
Q1 24
$1.2M
$-8.9M
Gross Margin
MTEX
MTEX
NPCE
NPCE
Q4 25
77.4%
Q3 25
76.4%
77.4%
Q2 25
77.1%
Q1 25
74.3%
77.0%
Q4 24
80.6%
75.4%
Q3 24
74.5%
73.2%
Q2 24
77.1%
73.4%
Q1 24
78.6%
73.6%
Operating Margin
MTEX
MTEX
NPCE
NPCE
Q4 25
-6.6%
Q3 25
6.9%
-9.5%
Q2 25
-29.0%
Q1 25
-3.1%
-22.9%
Q4 24
3.0%
-17.0%
Q3 24
2.8%
-20.1%
Q2 24
-4.1%
-32.4%
Q1 24
2.8%
-41.6%
Net Margin
MTEX
MTEX
NPCE
NPCE
Q4 25
-10.3%
Q3 25
6.6%
-12.8%
Q2 25
-36.8%
Q1 25
-5.8%
-29.3%
Q4 24
7.8%
-24.5%
Q3 24
-1.0%
-25.9%
Q2 24
-2.2%
-39.0%
Q1 24
4.0%
-49.2%
EPS (diluted)
MTEX
MTEX
NPCE
NPCE
Q4 25
$-0.08
Q3 25
$1.01
$-0.11
Q2 25
$-0.26
Q1 25
$-0.80
$-0.21
Q4 24
$1.19
$-0.16
Q3 24
$-0.17
$-0.19
Q2 24
$-0.33
$-0.26
Q1 24
$0.63
$-0.32

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
MTEX
MTEX
NPCE
NPCE
Cash + ST InvestmentsLiquidity on hand
$7.1M
$61.1M
Total DebtLower is stronger
$2.9M
Stockholders' EquityBook value
$7.0M
$19.0M
Total Assets
$33.9M
$105.6M
Debt / EquityLower = less leverage
0.42×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
MTEX
MTEX
NPCE
NPCE
Q4 25
$61.1M
Q3 25
$7.1M
$60.0M
Q2 25
$62.1M
Q1 25
$9.3M
$66.3M
Q4 24
$11.4M
$52.8M
Q3 24
$12.2M
$56.8M
Q2 24
$9.2M
$55.5M
Q1 24
$7.9M
$58.9M
Total Debt
MTEX
MTEX
NPCE
NPCE
Q4 25
Q3 25
$2.9M
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24
Stockholders' Equity
MTEX
MTEX
NPCE
NPCE
Q4 25
$19.0M
Q3 25
$7.0M
$18.5M
Q2 25
$19.4M
Q1 25
$7.6M
$24.3M
Q4 24
$8.6M
$8.0M
Q3 24
$10.0M
$9.8M
Q2 24
$8.2M
$9.9M
Q1 24
$10.4M
$14.3M
Total Assets
MTEX
MTEX
NPCE
NPCE
Q4 25
$105.6M
Q3 25
$33.9M
$107.3M
Q2 25
$106.1M
Q1 25
$36.7M
$110.2M
Q4 24
$36.1M
$94.6M
Q3 24
$40.6M
$96.3M
Q2 24
$39.9M
$94.4M
Q1 24
$41.1M
$98.9M
Debt / Equity
MTEX
MTEX
NPCE
NPCE
Q4 25
Q3 25
0.42×
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
MTEX
MTEX
NPCE
NPCE
Operating Cash FlowLast quarter
$-1.3M
$506.0K
Free Cash FlowOCF − Capex
$-2.0M
$409.0K
FCF MarginFCF / Revenue
-6.8%
1.5%
Capex IntensityCapex / Revenue
2.4%
0.4%
Cash ConversionOCF / Net Profit
-0.68×
TTM Free Cash FlowTrailing 4 quarters
$-1.2M
$-11.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
MTEX
MTEX
NPCE
NPCE
Q4 25
$506.0K
Q3 25
$-1.3M
$-1.9M
Q2 25
$-2.1M
Q1 25
$-1.4M
$-7.5M
Q4 24
$-219.0K
$-4.8M
Q3 24
$3.3M
$-1.7M
Q2 24
$-2.7M
$-3.9M
Q1 24
$1.9M
$-7.5M
Free Cash Flow
MTEX
MTEX
NPCE
NPCE
Q4 25
$409.0K
Q3 25
$-2.0M
$-2.0M
Q2 25
$-2.3M
Q1 25
$-1.9M
$-7.5M
Q4 24
$-325.0K
$-4.8M
Q3 24
$3.0M
$-1.8M
Q2 24
$-2.7M
$-4.0M
Q1 24
$1.8M
$-7.6M
FCF Margin
MTEX
MTEX
NPCE
NPCE
Q4 25
1.5%
Q3 25
-6.8%
-7.2%
Q2 25
-9.6%
Q1 25
-7.0%
-33.4%
Q4 24
-1.1%
-22.5%
Q3 24
9.5%
-8.7%
Q2 24
-9.9%
-20.6%
Q1 24
6.2%
-42.1%
Capex Intensity
MTEX
MTEX
NPCE
NPCE
Q4 25
0.4%
Q3 25
2.4%
0.1%
Q2 25
0.7%
Q1 25
1.8%
0.2%
Q4 24
0.4%
0.2%
Q3 24
0.8%
0.5%
Q2 24
0.3%
0.3%
Q1 24
0.2%
0.6%
Cash Conversion
MTEX
MTEX
NPCE
NPCE
Q4 25
Q3 25
-0.68×
Q2 25
Q1 25
Q4 24
-0.10×
Q3 24
Q2 24
Q1 24
1.59×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Related Comparisons